| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 05/25/2004 | US6740512 Eukaryotic neutral sphingomyelinase (nsmase); used in drugs and in diagnosis |
| 05/25/2004 | US6740509 Method for the production of mucin-type glycopeptide |
| 05/25/2004 | US6740505 Culturing eukaryotic cells which produce proteins in a medium which comprises an alkanoic acid and/or salt at a maintained concentration |
| 05/25/2004 | US6740485 Identification of genes responsible for the virulence of staphylococcus bacteria, which allows for identification of new anti-bacterial agents and mutants that can be used as vaccines |
| 05/25/2004 | US6739531 Apparatus and method for rapid disruption of cells or viruses |
| 05/25/2004 | CA2159624C Method of encapsulating substances in biocapsules |
| 05/21/2004 | WO2004042037A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/21/2004 | WO2004042010A2 Modified luciferase nucleic acids and methods of use |
| 05/21/2004 | WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | WO2004041858A2 Improving growth characteristics of filamentous microorganisms |
| 05/21/2004 | WO2004041857A2 Mutant of clostridium difficile toxin b and methods of use |
| 05/21/2004 | WO2004041216A2 Ptpn11 (shp-2) mutations and cancer |
| 05/21/2004 | WO2004040988A1 Fishes treated with lactic acid bacterium culture medium having antibacterial and antixoidative effects |
| 05/21/2004 | WO2004040976A1 Cryogenically protected viral delivery systems and related manufacture and use |
| 05/21/2004 | WO2004040955A2 Microbiological method for producing ascorbic acid |
| 05/21/2004 | WO2004022709A3 Epitope sequences |
| 05/21/2004 | WO2004010762A3 System for controlling insects |
| 05/21/2004 | WO2004009759A8 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 05/21/2004 | WO2003104426A3 Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof |
| 05/21/2004 | WO2003102190A3 Bacterial polypeptides involved in viability |
| 05/21/2004 | WO2003089462A3 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003053135A9 Plant xrcc3 genes and methods of use |
| 05/21/2004 | WO2003042362A8 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 05/21/2004 | WO2002095014A9 Polypeptides having cellobiase activity and polynucleotides encoding same |
| 05/21/2004 | WO2002083869A9 Product and process for transformation of thraustochytriales microorganisms |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2002014467A8 Cng2b: a putative human cyclic nucleotide-gated ion channel |
| 05/21/2004 | WO2001066690A3 Novel compounds |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2505400A1 Improving growth characteristics of filamentous microorganisms |
| 05/21/2004 | CA2504762A1 P153 and p156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
| 05/21/2004 | CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit |
| 05/21/2004 | CA2502565A1 Fishes treated with lactic acid bacterium culture medium having antibacterial and antioxidative effects |
| 05/20/2004 | US20040098755 Comprises nucleotide sequences coding embryonic glycoprotein for use in the treatment and prevention of autoimmune, cell proliferative and immunological disorders; immunosuppressants; antiproliferative agents |
| 05/20/2004 | US20040097721 Pesticidal toxins and genes from Bacillus laterosporus strains |
| 05/20/2004 | US20040097720 Use of glycodendrimer reagents for inhibiting adhesion by microorganisms |
| 05/20/2004 | US20040097715 Recovering polypeptides which have leached from cells made porous via electric pulse |
| 05/20/2004 | US20040097708 Comprises nucleotide sequences coding membrane protein associated with odor detection for use in biological pest control |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097439 Useful to study, increase and/or reduce genes expression, and to improve DNA vaccination |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040097393 Use of a single cellulase with a ratio of tensile strength loss to antipilling properties in aqueous laundry solutions |
| 05/20/2004 | US20040096973 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 05/20/2004 | US20040096972 Chimeric plasmid comprising a replicative retroviral genome, and uses |
| 05/20/2004 | US20040096956 Trangenic cells for generation of immunoglobulins for detection, quantitation, purification and neutralization of antigens; therapeutic diagnostics |
| 05/20/2004 | US20040096952 Alpha-amylase variant with altered properties |
| 05/20/2004 | US20040096945 Nucleic acids and protein variants of hG-CSF with granulopoietic activity |
| 05/20/2004 | US20040096944 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 05/20/2004 | US20040096942 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/20/2004 | US20040096940 Novel polypeptides having opioid receptor activity, nucleic acids coding therefor and uses thereof |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096936 Comprises nucleotide sequences coding fibroblast growth factor (FGF) for treating cardiac disorders; tissue engineering; tissue-targeted gene therapy |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096890 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096889 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096861 For increase the drought tolerance of plants; gene expression inhibition |
| 05/20/2004 | US20040096850 For decreasing the phosphorus waste derived from monogastric animal nutrition; feeds |
| 05/20/2004 | US20040096822 HCV antigen/antibody combination assay |
| 05/20/2004 | US20040096466 Plasmodium falciparum antigens inducing protective antibodies |
| 05/20/2004 | US20040096465 Novel receptors for $1(helicobater pyroli) and use thereof |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096434 Agent for relieving intestinal disorders comprising live bacterial cells of a strain belonging to Lactobacillus helveticus, wherein said strain exhibits minimum growth inhibitory concentration of 0.8% or more dry solid bile in a |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040093795 Floral packaging material having great masters prints thereon |
| 05/19/2004 | EP1420067A1 Chondroitin synthase |
| 05/19/2004 | EP1420031A2 Bone morphogenetic protein (BMP)-18 compositions |
| 05/19/2004 | EP1419780A1 Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of senile dementia and Alzheimer's disease |
| 05/19/2004 | EP1419392A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419263A2 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same |
| 05/19/2004 | EP1419261A1 Permeabilisation of cells |
| 05/19/2004 | EP1419258A2 Plasmids from an extremely thermophilic microorganism and derived expression vectors |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419255A2 A novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases |
| 05/19/2004 | EP1419254A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 05/19/2004 | EP1419249A2 TIMM8b-RELATED PROTEIN |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419234A1 Method of fermentation |
| 05/19/2004 | EP1419179A2 Antigen binding domains from fish |
| 05/19/2004 | EP1418943A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1010753B1 Fermented soy-milk prepared with bifidobacterium breve yit 4065 |
| 05/19/2004 | EP1009842B1 Plasmids for plant transformation and method for using the same |
| 05/19/2004 | EP1007551B1 Vaccine against hpv |
| 05/19/2004 | EP0929659B1 Process for producing solid bodies and uses of said bodies |
| 05/19/2004 | EP0920493B1 Biodegradation of explosives |
| 05/19/2004 | EP0870026B1 Ob protein derivatives having prolonged half-life |
| 05/19/2004 | EP0870010B1 Fungal food |
| 05/19/2004 | EP0711173B1 Isolated peptides which form complexes with mhc molecule hla-c-clone 10 and uses thereof |
| 05/19/2004 | EP0650525B1 D-n-carbamoyl-amino acid amidohydrolase and hydantoinase |
| 05/19/2004 | DE10251747A1 Gentechnisch veränderte Penicillinamidase und Verfahren zu ihrer Herstellung Genetically modified penicillin and process for their preparation |
| 05/19/2004 | DE10229645A1 Zellaufschluss von Bakterien Cell disruption of bacteria |
| 05/19/2004 | CN1498270A Gene disrupted yeast |
| 05/19/2004 | CN1498265A Thermophilic microoganism bacillus coagulans strain SIM-TDSM 14043 for production of L(+)-lactate from fermentable sugars and their mixtures |
| 05/19/2004 | CN1498264A Ribonucleic acid-enriched brewer's yeast cells and process for producing the same |